-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Infliximab is a biologic anti-TNF-α, and used to treat a number of self- immune diseases, are widely used in the treatment of psoriasis, inflammatory bowel disease and other diseases
This study confirmed that despite stopping treatment and receiving corticosteroids, about half of patients with liver injury caused by infliximab had a slower improvement in ALT
Original source:
Helgi Kristinn Björnsson.
Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment.
Leave a message here